BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 12673843)

  • 1. Hemostatic alterations in sickle cell disease: relationships to disease pathophysiology.
    Stuart MJ; Setty BN
    Pediatr Pathol Mol Med; 2001; 20(1):27-46. PubMed ID: 12673843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-thalassaemia and sickle cell anaemia as paradigms of hypercoagulability.
    Ataga KI; Cappellini MD; Rachmilewitz EA
    Br J Haematol; 2007 Oct; 139(1):3-13. PubMed ID: 17854302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived microparticles.
    Gerotziafas GT; Van Dreden P; Chaari M; Galea V; Khaterchi A; Lionnet F; Stankovic-Stojanovic K; Blanc-Brude O; Woodhams B; Maier-Redelsperger M; Girot R; Hatmi M; Elalamy I
    Thromb Haemost; 2012 Jun; 107(6):1044-52. PubMed ID: 22535498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erythrocyte membrane sulfatide plays a crucial role in the adhesion of sickle erythrocytes to endothelium.
    Zhou Z; Thiagarajan P; Udden M; Lòpez JA; Guchhait P
    Thromb Haemost; 2011 Jun; 105(6):1046-52. PubMed ID: 21437360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sickle erythrocyte adherence to endothelium at low shear: role of shear stress in propagation of vaso-occlusion.
    Montes RA; Eckman JR; Hsu LL; Wick TM
    Am J Hematol; 2002 Jul; 70(3):216-27. PubMed ID: 12111767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombophilia in sickle cell disease: the red cell connection.
    Setty BN; Rao AK; Stuart MJ
    Blood; 2001 Dec; 98(12):3228-33. PubMed ID: 11719358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombin generation and cell-dependent hypercoagulability in sickle cell disease.
    Whelihan MF; Lim MY; Mooberry MJ; Piegore MG; Ilich A; Wogu A; Cai J; Monroe DM; Ataga KI; Mann KG; Key NS
    J Thromb Haemost; 2016 Oct; 14(10):1941-1952. PubMed ID: 27430959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombosis and sickle cell disease.
    De Franceschi L; Cappellini MD; Olivieri O
    Semin Thromb Hemost; 2011 Apr; 37(3):226-36. PubMed ID: 21455857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newer aspects of the pathophysiology of sickle cell disease vaso-occlusion.
    Conran N; Franco-Penteado CF; Costa FF
    Hemoglobin; 2009; 33(1):1-16. PubMed ID: 19205968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microvesicles in haemoglobinopathies offer insights into mechanisms of hypercoagulability, haemolysis and the effects of therapy.
    Westerman M; Pizzey A; Hirschman J; Cerino M; Weil-Weiner Y; Ramotar P; Eze A; Lawrie A; Purdy G; Mackie I; Porter J
    Br J Haematol; 2008 Jul; 142(1):126-35. PubMed ID: 18422994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemostatic activation in a chemically induced rat model of severe hemolysis and thrombosis.
    Lewis DA; Nyska A; Potti A; Hoke HA; Klemp KF; Ward SM; Peddada SD; Wu J; Ortel TL
    Thromb Res; 2006; 118(6):747-53. PubMed ID: 16405975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormal adherence of sickle erythrocytes to cultured vascular endothelium: possible mechanism for microvascular occlusion in sickle cell disease.
    Hebbel RP; Yamada O; Moldow CF; Jacob HS; White JG; Eaton JW
    J Clin Invest; 1980 Jan; 65(1):154-60. PubMed ID: 7350195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adhesion of erythrocytes to endothelium in pathological situations: a review article.
    Chappey O; Wautier-Pepin MP; Wautier JL
    Nouv Rev Fr Hematol (1978); 1994 Aug; 36(4):281-8. PubMed ID: 7971246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythrocyte adhesion in sickle cell disease.
    Parise LV; Telen MJ
    Curr Hematol Rep; 2003 Mar; 2(2):102-8. PubMed ID: 12901140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormality of erythrocyte membrane n-3 long chain polyunsaturated fatty acids in sickle cell haemoglobin C (HbSC) disease is not as remarkable as in sickle cell anaemia (HbSS).
    Ren H; Ghebremeskel K; Okpala I; Ugochukwu CC; Crawford M; Ibegbulam O
    Prostaglandins Leukot Essent Fatty Acids; 2006 Jan; 74(1):1-6. PubMed ID: 16314081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology and treatment of sickle cell disease.
    Raphael RI
    Clin Adv Hematol Oncol; 2005 Jun; 3(6):492-505. PubMed ID: 16167028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of hydroxyurea on the coagulation system in sickle cell anemia and beta-thalassemia intermedia patients: a preliminary study.
    Koc A; Gumruk F; Gurgey A
    Pediatr Hematol Oncol; 2003 Sep; 20(6):429-34. PubMed ID: 14631615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythrocyte/endothelial interactions in the pathogenesis of sickle-cell disease: a "real logical" assessment.
    Hebbel RP; Eaton JW; Steinberg MH; White JG
    Blood Cells; 1982; 8(1):163-73. PubMed ID: 7115974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sickle cell vaso-occlusion.
    Fabry ME; Kaul DK
    Hematol Oncol Clin North Am; 1991 Jun; 5(3):375-98. PubMed ID: 1864816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythrocyte adhesion is modified by alterations in cellular tonicity and volume.
    Wandersee NJ; Punzalan RC; Rettig MP; Kennedy MD; Pajewski NM; Sabina RL; Paul Scott J; Low PS; Hillery CA
    Br J Haematol; 2005 Nov; 131(3):366-77. PubMed ID: 16225657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.